Revisión en profundidad y guía para la práctica | 02 JUL 19

Hemorragia posparto

Revisión de las causas, el diagnóstico y el tratamiento de la hemorragia posparto dirigida a la atención médica obstétrica y posnatal
Autor/a: Edwin Chandraharan. Archana Krishna.  BMJ 2017;358:j3875
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

1 World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. WHO, 2012.

2 Knight M, Tuffnell D, Kenyon S, Shakespeare J, Gray R, Kurinczuk JJ (eds) on behalf of MBRRACE-UK. Saving lives, improving mothers’ care: Surveillance of maternal deaths in the UK 2011-13 and lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009-13. National Perinatal Epidemiology Unit, 2015.

3 Chandraharan E, Arulkumaran S. Massive postpartum haemorrhage and management of coagulopathy. Obstetrics, Gynaecol Reprod Med 2007;17:119-22doi:10.1016/j.ogrm. 2007.02.004.

4 Arulkumaran S, Decruz B. Surgical management of severe postpartum haemorrhage. Curr Obstet Gynaecol 1999;9:101-5doi:10.1016/S0957-5847(99)90008-2.

5 Mavrides E, Allard S, Chandraharan E, et al. Prevention and management of postpartum haemorrhage: Green-top Guideline No 52. BJOG 2016;124:e106-49.pmid:27981719.

6 McCandlish R, Bowler U, van Asten H, et al. A randomised controlled trial of care of the perineum during second stage of normal labour. Br J Obstet Gynaecol 1998;105:1262-72.doi:10.1111/j.1471-0528.1998.tb10004.x pmid:9883917. 7 Sleep J, Grant A, Garcia J, Elbourne D, Spencer J, Chalmers I. West Berkshire perineal management trial. Br Med J (Clin Res Ed) 1984;289:587-90. doi:10.1136/bmj.289.6445. 587 pmid:6432201.

8 Combs CA, Murphy EL, Laros RK Jr. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol 1991;77:69-76.pmid:1984230.

9 Brace V, Kernaghan D, Penney G. Learning from adverse clinical outcomes: major obstetric haemorrhage in Scotland, 2003-05. BJOG 2007;114:1388-96. doi:10.1111/j.1471-0528. 2007.01533.x pmid:17949379. 10 Belghiti J, Kayem G, Dupont C, Rudigoz RC, Bouvier-Colle MH, Deneux-Tharaux C. Oxytocin during labour and risk of severe postpartum haemorrhage: a population-based, cohort-nested case-control study. BMJ Open 2011;1:e000514. doi:10.1136/bmjopen-2011-000514 pmid:22189353.

11 Chandraharan E, Arulkumaran S. Management algorithm for atonic postpartum haemorrhage. J Paediatr Obstet Gynaecol 2005;31:106-12.

12 Ferrazzi E, Rigano S, Padoan A, Boito S, Pennati G, Galan HL. Uterine artery blood flow volume in pregnant women with an abnormal pulsatility index of the uterine arteries delivering normal or intrauterine growth restricted newborns. Placenta 2011;32:487-92. doi:10.1016/j.placenta.2011.04.004 pmid:21531458.

13 Bose P, Regan F, Paterson-Brown S. Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG 2006;113:919-24. doi:10. 1111/j.1471-0528.2006.01018.x pmid:16907938.

14 Le Bas A, Chandraharan E, Addei A, Arulkumaran S. Use of the “obstetric shock index” as an adjunct in identifying significant blood loss in patients with massive postpartum hemorrhage. Int J Gynaecol Obstet 2014;124:253-5. doi:10.1016/j.ijgo.2013.08.020 pmid: 24373705.

15 Nathan HL, El Ayadi A, Hezelgrave NL, et al. Shock index: an effective predictor of outcome in postpartum haemorrhage?BJOG 2015;122:268-75. doi:10.1111/1471-0528.13206 pmid: 25546050.

16 Varatharajan L, Chandraharan E, Sutton J, Lowe V, Arulkumaran S. Outcome of the management of massive postpartum hemorrhage using the algorithm “HEMOSTASIS”. Int J Gynaecol Obstet 2011;113:152-4. doi:10.1016/j.ijgo.2010.11.021 pmid:21396642.

17 Prendiville WJ, Harding JE, Elbourne DR, Stirrat GM. The Bristol third stage trial: active versus physiological management of third stage of labour. BMJ 1988;297:1295-300. doi: 10.1136/bmj.297.6659.1295 pmid:3144366.

18 Prata N, Bell S, Weidert K. Prevention of postpartum hemorrhage in low-resource settings: current perspectives. Int J Womens Health 2013;5:737-52. doi:10.2147/IJWH.S51661 pmid: 24259988.

19 Novikova N, Hofmeyr GJ, Cluver C. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2015;(6):CD007872. doi:10.1002/14651858. CD007872.pub3. pmid:26079202.

20 Elati A, Weeks A. Misoprostol for the management of postpartum haemorrhage. BMJ 2011;342:d2877. doi:10.1136/bmj.d2877 pmid:21571915.

21 Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev 2014;(2):CD003249. doi:10. 1002/14651858.CD003249.pub3. pmid:24523225.

22 Quibel T, Ghout I, Goffinet F, et al. Groupe de Recherche en Obstétrique et Gynécologie (GROG). Active management of the third stage of labor with a combination of oxytocin and misoprostol to prevent postpartum hemorrhage: a randomized controlled trial. Obstet Gynecol 2016;128:805-11. doi:10.1097/AOG.0000000000001626 pmid:27607864.

23 Su LL, Chong YS, Samuel M. Carbetocin for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2012;(2):CD005457. doi:10.1002/14651858.CD005457. pub3. pmid:22336812.

24 Tindell K, Garfinkel R, Abu-Haydar E, et al. Uterine balloon tamponade for the treatment of postpartum haemorrhage in resource-poor settings: a systematic review. BJOG 2013;120:5-14. doi:10.1111/j.1471-0528.2012.03454.x pmid:22882240. 25 Chandraharan E, Arulkumaran S. Surgical aspects of postpartum haemorrhage. Best Pract Res Clin Obstet Gynaecol 2008;22:1089-102. doi:10.1016/j.bpobgyn.2008.08. 001 pmid:18790675.

26 Doumouchtsis SK, Papageorghiou AT, Arulkumaran S. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstet Gynecol Surv 2007;62:540-7. doi:10.1097/01.ogx.0000271137.81361.93 pmid:17634155.

27 WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN):an international, randomised, double-blind, placebo-controlled trial. Lancet 2017;389:2105-16. doi:10.1016/S0140-6736(17)30638-4 pmid:28456509.

28 Roberts I, Shakur H, Coats T, et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess 2013;17:1-79. doi:10.3310/hta17100 pmid:23477634.

29 Holcomb JB, Tilley BC, Baraniuk S, et al. PROPPR Study Group. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma PROPPR randomized clinical trial. JAMA 2015;313:471-82. doi:10.1001/jama. 2015.12 pmid:25647203.

30 Khong TY, Robertson WB. Placenta creta and placenta praevia creta. Placenta 1987;8:399-409. doi:10.1016/0143-4004(87)90067-1 pmid:3684969.

31 Chandraharan E, Rao S, Belli AM, Arulkumaran S. The Triple-P procedure as a conservative surgical alternative to peripartum hysterectomy for placenta percreta. Int J Gynaecol Obstet 2012;117:191-4. doi:10.1016/j.ijgo.2011.12.005 pmid:22326782.

32 Teixidor Viñas M, Belli AM, Arulkumaran S, Chandraharan E. Prevention of postpartum hemorrhage and hysterectomy in patients with morbidly adherent placenta: a cohort study comparing outcomes before and after introduction of the Triple-P procedure. Ultrasound Obstet Gynecol 2015;46:350-5. doi:10.1002/uog.14728 pmid:25402727.



Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí